Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) – USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Warrant [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Jul. 31, 2020 $ 2,305  $ 214,789,808  $ 5,708,127  $ (19,504)  $ (206,610,300)  $ 13,870,436 
Balance, shares at Jul. 31, 2020 23,054,474    3,114,288       
Stock-based compensation expense $ 2  3,213,748        3,213,750 
Stock-based compensation expense, shares 19,623           
Tax withholdings paid on equity awards   (53,438)        (53,438) 
Tax shares sold to pay for tax withholdings on equity awards   54,191        54,191 
Other comprehensive income (loss)       (336,310)    (336,310) 
Net loss         (33,371,690)  (33,371,690) 
Common stock issued for services $ 10  339,990        340,000 
Common stock issued for services, shares 100,000           
Exercise of common stock options $ 30  489,550        489,580 
Exercise of common stock options, shares 294,884           
Common stock issued for employee stock purchase plan   5,798        5,798 
Common stock issued for employee stock purchase plan, shares 1,538           
Exercise of common stock warrants $ 139  6,580,106  $ (1,787,294)      4,792,951 
Exercise of common stock warrants, shares 1,389,261    (1,389,261)       
Purchase of shares under CGP and Sirtex stock purchase agreements $ 169  5,836,562        5,836,731 
Purchase of shares under CGP and Sirtex stock purchase agreements, shares 1,691,806           
Dividends declared ($0.00 per share)            
Cancellation of expired warrants   242,143  $ (242,143)       
Cancellation of expired warrants, shares     (10,712)       
August 2020 Registered Direct Offering, net of $1,464,276 issuance costs $ 461  13,513,177        13,513,638 
August 2020 Registered Direct Offering, net of $1,464,276 issuance costs, shares 4,608,589           
January 2021 Public Offering, net of $2,970,165 issuance costs $ 771  39,055,561        39,056,332 
January 2021 Public Offering, net of $2,970,165 issuance costs, shares 7,711,284           
Ending balance, value at Apr. 30, 2021 $ 3,887  284,067,196  $ 3,678,690  (355,814)  (239,981,990)  47,411,969 
Ending balance, shares at Apr. 30, 2021 38,871,459    1,714,315       
Beginning balance, value at Jan. 31, 2021 $ 3,649  274,633,208  $ 4,330,949  (285,323)  (230,539,664)  48,142,819 
Balance, shares at Jan. 31, 2021 36,491,976    2,221,315       
Stock-based compensation expense $ 1  841,569        841,570 
Stock-based compensation expense, shares 6,541           
Tax withholdings paid on equity awards   (26,979)        (26,979) 
Tax shares sold to pay for tax withholdings on equity awards   26,142        26,142 
Other comprehensive income (loss)       (70,491)    (70,491) 
Net loss         (9,442,326)  (9,442,326) 
Common stock issued for services $ 4  127,496        127,500 
Common stock issued for services, shares 37,500           
Exercise of common stock options $ 13  227,840        227,853 
Exercise of common stock options, shares 136,636           
Exercise of common stock warrants $ 51  2,401,358  $ (652,259)      1,749,150 
Exercise of common stock warrants, shares 507,000    (507,000)       
Purchase of shares under CGP and Sirtex stock purchase agreements $ 169  5,836,562        5,836,731 
Purchase of shares under CGP and Sirtex stock purchase agreements, shares 1,691,806           
Dividends declared ($0.00 per share)            
Ending balance, value at Apr. 30, 2021 $ 3,887  284,067,196  $ 3,678,690  (355,814)  (239,981,990)  47,411,969 
Ending balance, shares at Apr. 30, 2021 38,871,459    1,714,315       
Beginning balance, value at Jul. 31, 2021 $ 3,916  286,337,291  $ 3,591,734  (79,109)  (251,778,031)  38,075,801 
Balance, shares at Jul. 31, 2021 39,152,610    1,706,190       
Stock-based compensation expense $ 7  1,272,266        1,272,273 
Stock-based compensation expense, shares 67,839           
Tax withholdings paid on equity awards   (43,383)        (43,383) 
Tax shares sold to pay for tax withholdings on equity awards   42,949        42,949 
Other comprehensive income (loss)       257,840    257,840 
Net loss         (25,963,350)  (25,963,350) 
Common stock issued for services $ 1  42,499        42,500 
Common stock issued for services, shares 12,500           
Exercise of common stock options $ 13  202,787        202,800 
Exercise of common stock options, shares 130,000           
Common stock issued for employee stock purchase plan   1,185        1,185 
Common stock issued for employee stock purchase plan, shares 1,500           
Purchase of shares under CGP and Sirtex stock purchase agreements            
Ending balance, value at Apr. 30, 2022 $ 3,937  287,855,594  $ 3,591,734  178,731  (277,741,381)  13,888,615 
Ending balance, shares at Apr. 30, 2022 39,364,449    1,706,190       
Beginning balance, value at Jan. 31, 2022 $ 3,935  287,539,711  $ 3,591,734  173,874  (271,494,076)  19,815,178 
Balance, shares at Jan. 31, 2022 39,349,269    1,706,190       
Stock-based compensation expense $ 2  315,697        315,699 
Stock-based compensation expense, shares 15,180           
Tax withholdings paid on equity awards   (10,378)        (10,378) 
Tax shares sold to pay for tax withholdings on equity awards   10,564        10,564 
Other comprehensive income (loss)       4,857    4,857 
Net loss         (6,247,305)  (6,247,305) 
Ending balance, value at Apr. 30, 2022 $ 3,937  $ 287,855,594  $ 3,591,734  $ 178,731  $ (277,741,381)  $ 13,888,615 
Ending balance, shares at Apr. 30, 2022 39,364,449    1,706,190